Aducanumab for Alzheimer's disease: expediting approval and delaying science.

BMJ Evid Based Med

Departamento de Ciencias Neurológicas, Universidad de Chile, Santiago de Chile, Chile

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjebm-2021-111765DOI Listing

Publication Analysis

Top Keywords

aducanumab alzheimer's
4
alzheimer's disease
4
disease expediting
4
expediting approval
4
approval delaying
4
delaying science
4
aducanumab
1
disease
1
expediting
1
approval
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!